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ABSTRACT 
International Journal of Exercise Science 13(3): 1340-1351, 2020. Currently, there are no established 
evidence-based rating of perceived exertion (RPE) targets for physical activity (PA) in pregnant women. Yet, a set 
of target heart rate (HR) ranges have been recommended. Using the Borg Scale, we aimed to determine and validate 
the RPE target ranges for different PA intensities derived from the recommended HR ranges in the 2019 Canadian 
Guideline for PA throughout pregnancy. We assessed 13 pregnant women (age: 31.2 ± 3.5 years; gestational age: 
20.5 ± 5.0 weeks) using the following three phases: 1) the incremental submaximal walking test to develop the linear 
regression equation; 2) establishment of the RPE targets for light- and moderate-intensity PA; 3) moderate-intensity 
exercise session aiming to cross-validate RPE targets in women whose HR ranges were within (Step 1; six 
participants; 36 RPE values) or outside (Step 2; seven participants; 42 RPE values) the guideline. Study Phase 1 
showed a strong linear relationship between RPE x HR (RPE = -7.370 + 0.155*HR; R2 = 0.863). RPE targets for 
pregnant women aged ≤ 29 years are 8-12 (light-intensity) and 12-15 (moderate-intensity), respectively. For women 
aged ≥ 30 years, RPE targets are 8-11 (light-intensity) and 11-14 (moderate-intensity), respectively. The cross-
validation suggested no differences between predicted (13.4 ± 0.7) vs. observed RPE (13.3 ± 1.4; p = 0.703) and a 
strong % agreement (Step 1 = 80.6%; Step 2 = 73.8%) between observed RPE and its predicted range. Thus, we have 
determined pregnancy-specific, evidence-based RPE targets. These RPE targets will help exercise professionals, 
other health care providers, and pregnant women to easily monitor exercise intensity during pregnancy to meet 
recommended Canadian PA Guideline. 
 




Recently, the “2019 Canadian Guideline for Physical Activity (PA) throughout Pregnancy” (referred 
throughout the text as the Canadian PA Guideline) was released by the Society of Obstetricians 
and Gynaecologists of Canada (SOGC) and the Canadian Society for Exercise Physiology 
(CSEP). It is an evidence-based guideline substantiated by extensive systematic reviews and 
meta-analyses. It also takes into account the user’s point of view, including obstetric care 
providers, exercise professionals, researchers, policy organizations, as well as pregnant and 
postpartum women, and is founded on feasibility, acceptability, costs, and equity aspects (19). 
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Based on the results of a set of systematic reviews, this current guideline states that pregnant 
women should aim to achieve at least 150 min of moderate-intensity PA over three or more days 
per week (19). Their findings suggest that meeting the recommendations is associated with 
reductions in the odds of developing different pregnancy complications, such as gestational 
diabetes mellitus and/or hypertension, as well as pre-eclampsia (12). Although there is a dose-
response relationship between increasing exercise intensity and decreasing odds of developing 
depressive symptoms, insulin resistance, gestational diabetes, and hypertension, and pre-
eclampsia (11-13), light-intensity PA has also been shown to be beneficial (19). 
 
The recommendation of moderate-intensity PA, defined as 40-59% HR reserve (HRR) 
corresponding to reserve oxygen uptake (10), is comparable to the recent American College of 
Sports Medicine (ACSM) heart rate (HR) targets for exercise during pregnancy (2). This 
percentage range (i.e., 40-59%) originates from previous ACSM guidelines for prescribing 
exercise intensities (3) and follows the position statement on PA and exercise intensity 
terminologies (2, 21). 
 
Another method to monitor PA intensity in pregnant women suggested by the Canadian PA 
Guideline is by using the “talk test”. For this test, women are advised to remain at a “comfortable 
intensity” representing the ability to hold a conversation while physically active. If they cannot 
maintain a conversation, the intensity should be reduced (19). The “talk test”, however, is 
limited in its scope as it can only measure intensity changes from moderate- to higher intensities, 
but fails to take into consideration changes in different exercise and PA intensity ranges (e.g., 
light- to moderate-intensity). 
 
The position statement on physical activity and exercise intensity terminology (21) suggests that 
an alternative subjective measure of exercise intensity could be used; rating of perceived 
exertion (RPE), also known as Borg RPE scales (6). Of the existing scales, the 15-point scale that 
ranges from 6-20, is the most widely used and is recommended for exercise testing and 
prescription (6). This scale was developed in an attempt to provide a user-friendly measure that 
increases linearly with intensity, similar to the responses of HR (6). Indeed, stress responses 
measured by physiological markers (e.g., blood lactate concentrations, HR, oxygen 
consumption) (6, 15, 21) increase positively and linearly with PA intensity. These physiological 
changes are cognitively perceived as a sensation of physical effort (21), which makes the Borg 
RPE scale useful in PA intensity monitoring. According to Borg (5), RPE complements HR 
responses to physical effort. 
 
With that in mind, previous guidelines from SOGC/CSEP (14) had included Borg RPE scale 
target ranges for moderate-intensity PA (i.e., 12 to 14 on the 6-20 scale); however, the quality of 
evidence and classification of recommendations were considered poor, given that no target RPE 
values were derived from research in pregnant women. Due to the lack of evidence from the 
pregnant population, the current Canadian PA Guideline (19) does not mention RPE as a tool to 
monitor exercise intensity. Unlike the Canadian PA Guideline, the last American College of 
Obstetricians and Gynecologists (1) exercise guideline did advocate a range of 13-14 on the Borg 
RPE scale equivalent to moderate-intensity exercise. The ACOG (1) recommends the use of RPE 
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in addition to HR for monitoring PA intensity due to the reported altered HR responses in 
pregnant women (18, 24). Nevertheless, ACOG’s suggested RPE ranges are not based on 
evidence in pregnant women or on other physiological responses/recommendations for this 
population. 
 
The HR targets published by Davenport et al. (10) are considered the up-to-date reference for 
light- and moderate-intensity PA during pregnancy and are included in different guidelines for 
physical activity throughout pregnancy (2, 19). However, monitoring the proposed HR targets 
may present a real-life challenge to women without a HR measuring device. Another issue 
related to HR is the variable accuracy of different wearable HR monitors during aerobic exercise 
at light- and moderate-intensities (16). 
 
Thus, our goal was to establish RPE target ranges for different PA intensities gleaned from the 
recommended HR ranges in the current Canadian PA Guideline (19) for pregnant women. To 
determine corresponding RPE ranges to match HR values, we developed an equation that 
estimates appropriate RPE target ranges for different PA intensities. We hypothesized that 
appropriate RPE ranges would be determined and cross-validated in a simulated bout of 





Thirteen pregnant women were recruited for participation using social media and flyers. 
Eligibility criteria were as follows: maternal age of 18-40 years, carrying a singleton fetus, no 
contraindications to exercise, and a self-reported pre-pregnancy body mass index (BMI) 
between 18.5 – 29.9 kg/m2, and 13-28 weeks of gestation (2nd trimester of pregnancy). Although 
the gestational age range we selected was wide, Pivarnik et al. (23) found no differences in HR 
and RPE responses during exercise across this time point (i.e., the 2nd trimester of pregnancy). 
Those with gestational diabetes, hypertension, or untreated thyroid disease were excluded. All 
experimental procedures were approved by the local Research Ethics Board (H-06-18-634). 
Study procedures were explained in person, after which informed written consent was obtained 
from all study participants. This research was carried out in accordance with the ethical 
standards of the International Journal of Exercise Science (20). 
 
Protocol 
The study design is outlined in Figure 1. The procedures are detailed below. 
 
Participants were asked to visit the lab following a minimal 8 h fast and to abstain from exercise 
for 12 h before the session. Height and body weight were measured using a Tanita HR-200 wall-
mounted stadiometer (accuracy: 0.1cm; Lachine, QC) and Tanita BWB-800 scale, respectively. 
The study protocol required participants to arrive fasted for a baseline blood draw, followed by 
a standardized (~400 kcal) snack before the exercise session. The participants were fasted 
overnight as the current study was part of a larger study assessing blood biomarkers in 
pregnancy. 
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Figure 1. Study design. HR = heart rate; PA = physical activity; RPE = rating of perceived exertion. 
 
Resting HR was determined by obtaining the average HR recorded at 1 min intervals during the 
last 5 min of a 10 min seated resting phase. 
 
The first part of the exercise session consisted of an incremental submaximal walking test 
conducted using a Woodway Pro XL 27 treadmill (Woodway USA, Waukesha, WI) described as 
follows: 3 min warm-up at a speed of 2.0 miles per hours (mph) and an incline of 2.0%. Then, 
the incline increased to 6.0%, with speed increasing by 0.2 mph at 1-min intervals. HR was 
continuously measured using a Polar V800 watch (Polar Electro Canada, Lachine, QC) until the 
target calculated moderate-intensity HR range was reached (i.e., the upper limit of the 40-59% 
of HRR range). This target is consistent with the Canadian PA Guideline (19). The following 
equation was employed to determine the moderate-intensity target HR range using the 
following calculation: %HRR = [(HRmax – resting HR)* %intensity] + resting HR; where HRmax 
= 220 – age. 
 
Along with HR monitoring throughout the incremental submaximal walking test, RPE values 
were recorded using the 6-20 Borg Scale (6) 15 seconds before the end of each stage of the test. 
From the HR data, HR values were pooled at the same time RPE was collected in order to create 
the linear regression equations (Study Phase 1) and subsequently develop the RPE targets for 
light- and moderate-intensity PA (Study Phase 2).  
 
Moderate-intensity exercise session (Study Phase 3): Once the upper limit of the 40-59% HRR 
range was achieved in the incremental submaximal walking test, the participants continued to 
exercise at moderate-intensity for 30 min as close as possible to the upper limit of the 40-59% 
HRR range using the same treadmill and with continuous measurement of HR as described 
above. The speed was adjusted accordingly to ensure that the target moderate-intensity HR 
range was maintained. RPE and HR were recorded every 5 min (i.e., 5th, 10th, 15th, 20th, 25th, 
and 30th minutes) until the completion of the exercise session. A 30-min moderate-intensity 
exercise session was chosen to replicate a suggested bout of prenatal PA (19).  
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To cross-validate RPE targets, Study Phase 3 was further divided into two steps (Steps 1 and 2). 
Separation of study processes was necessary because some of our participants were found to be 
exercising outside of the recommended HR targets based on findings from Davenport et al. (10). 
This identification of exercise intensities outside the recommended range is due to differences 
in observed resting HR (used to calculate 40-59% HRR) in our study population compared to 
those in Davenport et al. (10).  
 
Thus, in Step 1 the observed RPE values obtained from the 5th-30th minutes of the moderate-
intensity exercise session were compared with the predicted RPE values from the developed 
equation (Study Phase 1) for women whose HR ranges were within the guideline 
recommendations (n = 6 participants; total of 36 RPE values) according to their individualized 
40-59% HRR target ranges (10). In Step 2 of the cross-validation of the RPE targets, we used the 
observed RPE values from seven participants whose suggested moderate-intensity HR ranges 
fell outside the guideline recommendations. Assuming that the exercise session for this group 
was also considered a moderate-intensity exercise bout, we used observed RPE values in the 




A power analysis conducted using G*POWER 3.1 (Universitat Kiel, Germany) determined that 
a minimum of 11 participants were required in the present study for a power of 80%, an effect 
size of 0.7, and an α = 0.05. The effect size of 0.7 was determined based on the results of a large 
(n = 2560) (non-pregnant) cohort study (25) examining the association between HR and RPE 
during an incremental exercise test. 
 
Data are presented as mean ± standard deviation, and the Shapiro-Wilk normality test was used 
to determine if parametric (paired t-test) or non-parametric (Wilcoxon test) tests would be used 
in the comparison analysis.  
 
Statistical analysis followed similar procedures described previously by Davenport et al. (8) to 
establish the cut-off points for HR described in the Canadian PA Guideline. In Study Phase 1, 
linear regression equations were developed for each of the 13 participants. The regression 
equations and other linear regression variables were pooled to determine mean values for the 
final equation. A one-sample t-test was used to compare mean intercept and slope with the line 
of identity (Intercept = 0; Slope = 1) to verify whether HR and RPE were equivalent. 
 
Subsequently, in Study Phase 2, HR targets were pooled from the Canadian PA Guideline (17) and 
applied to the equation to determine the RPE targets for light- and moderate-intensity PA, 
considering that the incremental submaximal walking test only included these intensity zones. 
RPE targets were developed for women aged ≤ 29 years and ≥ 30 years separately, as also 
presented in the Canadian PA Guideline for HR targets during PA. 
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The final phase of the analysis (Study Phase 3) was the cross-validation of the RPE targets, 
separated in two steps. In Step 1, the observed RPE values obtained at 5th, 10th, 15th, 20th, 25th, 
and 30th minutes of the moderate-intensity exercise session were compared with the predicted 
RPE values from the developed equation (HR x RPE) for women whose HR ranges were within 
the guideline recommendations (n = 6 participants; total of 36 RPE values; Wilcoxon test) 
according to their individualized 40-59% HRR target ranges (10). We also calculated the 
percentage of agreement (% agreement = [n of agreements / total sample size] * 100) between 
the observed RPE values and the predicted RPE targets derived from the HR ranges for the 
moderate-intensity exercise session (total of 36 RPE values). This percentage value was also 
classified according to McHugh (17) to determine the level of agreement (0-4% None; 4-15% 
Minimal; 15-35% Weak; 35-63% Moderate; 64-81% Strong; 82-100% Almost Perfect).  
 
In Step 2 of the cross-validation of the RPE targets, we used the observed RPE values from seven 
participants whose suggested moderate-intensity HR ranges were outside the guideline 
recommendations. Assuming that the exercise session for this group was also considered a 
moderate-intensity exercise bout, we used observed RPE values in the seven women captured 
at the 5th, 10th, 15th, 20th, 25th, and 30th minutes (total of 42 RPE values) of the exercise session 
and analyzed the percentage of agreement described above with the RPE targets derived from 
the HR cut-offs. 
 
Participants in Step 1 and 2 of Study Phase 3 were compared with regards their descriptive 
characteristics using the Mann-Whitney test or unpaired t-test, according to the normality test 




The characteristics of pregnant women participating in the present study, as well as the 
subgroup analyzed in the cross-validation procedure, are described in Table 1. The incremental 
submaximal walking test lasted, on average, 10 ± 2 min. 
 
The regression equation for HR vs. RPE was significantly different from the line of identity 
(slope = 1; intercept = 0), as presented in Table 2. The proportion of variability from one variable 
explained by the other was determined according to the coefficient of determination of the 
model, which was R2 = 0.863 for the raw analysis and R2 = 0.836 for the adjusted analysis. Other 
parameters of the linear regression are described in Table 3 (Study Phase 1). 
 
The RPE targets were calculated by applying the HR values described in the Canadian PA 
Guideline in the regression equation developed in the Study Phase 1. The derived RPE targets 
for light- and moderate-intensity PA are described in Table 4 (Study Phase 2). 
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Table 1. Study population characteristics. 
Demographics Equation development (n = 13) 
Cross-validation 1 
(n = 6) 
Cross-validation 2 
(n = 7) 
Age (years) 31.2 ± 3.5 33.5 ± 3.3 29.3 ± 2.6* 
Gestational age (weeks) 20.5 ± 5.0 18.8 ± 5.5 22.0 ± 4.4 
Height (cm) 166.7 ± 5.4 167.7 ± 4.0 165.8 ± 6.5 
Weight at visit (kg) 69.6 ± 10.3 70.2 ± 11.0 69.0 ± 10.5 
Gestational weight gain (kg) 5.8 ± 3.9 4.8 ± 4.3 6.7 ± 4.3 
Pre-pregnant body weight (kg) 63.7 ± 9.5 65.4 ± 9.5 62.3 ± 10.0 
Pre-pregnant BMI (kg·m-2) 23.7 ± 3.6 23.4 ± 3.9 24.0 ± 3.5 
Resting HR (bpm) 81 ± 14.5 73 ± 11 89 ± 14* 
Incremental submaximal walking test    
Speed to reach the upper limit of 40-59% 
HRR (mph) 3.4 ± 0.4 3.7 ± 0.5 3.4 ± 0.3 
Moderate-intensity exercise session    
40% HRR (bpm) 125 ± 9.5 119 ± 6.1 130 ± 9.2* 
60% HRR (bpm) 146 ± 7.1 141 ± 4.2 150 ± 6.8* 
Note. *p < 0.05. BMI = body mass index; HR = heart rate; HRR = heart rate reserve; bpm = beats per minute. 
 
 
Table 2. Means and standard deviation for the intercept and slope of linear regression analysis for RPE predicted 
from HR (n = 13). 
RPE vs. HR Mean ± SD p-value for the line of identity 
Intercept -7.370 ± 5.849 0.002a 
Slope 0.155 ± 0.050 < 0.001b 
Note. RPE = rating of perceived exertion; HR = heart rate; SD = standard deviation. aSignificantly different than 0. 
bSignificantly different than 1. 
 
 
Table 3. R-value, p-value from the correlation, coefficient of determination, adjusted coefficient of determination, 
and standard error of estimation derived from the linear regression to predict RPE based on HR. 
  R-value (correlation) p-value (correlation) R2 Adjusted R2 SEE 
RPE vs. HR 0.933 0.005 0.863 0.836 0.801 
Note. RPE = rating of perceived exertion; HR = heart rate; SEE = standard error of estimation. 
 
 
Table 4. RPE targets predicted according to the HR targetsa described in the 2019 Canadian Guideline for PA 
throughout pregnancy. 
Maternal age (years) Intensity HR targets (bpm) RPE targetsb (Borg scale 6-20) 
≤ 29 
Light 102-124 8-12 
Moderate 125-146 12-15 
≥ 30 
Light 101-120 8-11 
Moderate 121-141 11-14 
Note. aHR targets were pooled and adapted from Mottola et al.1. bRPE targets were determined based on the 
equation RPE = -7.370 + 0.155*HR. bpm = beats per minute; HR = heart rate; RPE = rating of perceived exertion. 
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When our equation was used in the first step of cross-validation analyses (36 RPE observations), 
predicted RPE (13.4 ± 0.7) based on the HR obtained in the 30-min moderate-intensity exercise 
session was not different from the observed RPE (13.3 ± 1.4) obtained throughout the exercise 
session (p = 0.703). We also compared the predicted and observed RPE values only in the first 
15-min (1st half) as well as in the last 15-min (2nd half of the exercise session). For both first (18 
RPE observations) and last half (18 RPE observations) of the exercise session, there was no 
difference between predicted and observed RPE values (Predicted RPE = 13.4 ± 0.7; Observed 
RPE = 13.6 ± 1.2; p = 0.624 for 1st half and predicted RPE = 13.4 ± 0.7; Observed RPE = 13.0 ± 1.6; 
p = 0.372 for 2nd half). 
 
The percentage agreement between the observed RPE and RPE targets for moderate-intensity 
exercise (RPE of 12-15 for ≤ 29 years old pregnant women and RPE of 11-14 for ≥ 30 years old 
pregnant women; Table 4) was calculated for the six women engaged in Step 1 of cross-
validation (36 RPE observations) and revealed 80.6% agreement (classified as a ‘strong’ level of 
agreement). The percentage agreement was also determined for the seven women in Step 2 (42 





An important outcome of the study is the development and cross-validation of RPE ranges for 
light- and moderate-intensity PA for pregnant women. For those aged ≤ 29 years, light-intensity 
PA RPE targets are 8-12 on the 6-20 Borg RPE scale, whereas moderate-intensity corresponds to 
12-15. Women aged ≥ 30 years should associate light-intensity PA to RPE scores of 8-11 and 
moderate-intensity to 11-14, using the same scale.  
 
The HR targets published by Davenport et al. (10), considered the up-to-date reference for light- 
and moderate-intensity PA during pregnancy, are those associated with the exercise guidelines 
in this population (2, 19). While HR targets are an excellent tool for those with access to a HR 
monitor, this strategy is not realistic for monitoring PA intensity in all women. Additionally, 
there are concerns regarding the accuracy and reliability of different commercially-available HR 
monitors, specifically during aerobic exercise conducted at light- or moderate-intensities (16). 
 
Although RPE, a relatively simple perceptual tool with high practical application, has 
previously been included in pregnancy-related PA guidelines as a surrogate measure for 
moderate-intensity PA monitoring, the quality of evidence for its inclusion lacked rigor (14). As 
such, our study is the first to address this shortcoming and provide RPE targets for light- and 
moderate-intensity exercise during pregnancy. We do not include RPE targets corresponding to 
vigorous-intensity PA (i.e., 60-79% HRR) for two reasons. First, the incremental submaximal 
walking test used to determine the predictive equation was designed to have women exercise 
at the recommended moderate-intensity range. Thus, vigorous-intensity HR and RPE values 
were not captured. During incremental exercise tests, including the vigorous-intensity range, 
participant data illustrate a change from the linear HR-exercise intensity relationship, referred 
to as the HR deflection point (8). The departure from linearity is generally reflected as a concave 
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trend in the HR curve (9). However, this curve has a wide range of inter-subject variability, 
allowing the observation of not only concave but also convex and linear trends (5). 
Consequently, extrapolating RPE values for vigorous-intensity HR targets from light- and 
moderate-intensities could be premature.  
 
The second reason as to why vigorous-intensity RPE targets were omitted from our study is that 
the Canadian PA Guideline recommends vigorous-intensity PA only in a monitored environment 
(19). Additionally, there is still a lack of information regarding the benefits of exercising within 
this higher intensity range, especially with-respect-to the upper limit, which prompted the 
Canadian PA Guideline to recommend that pregnant women consult their obstetric care provider 
before starting a vigorous-intensity exercise regimen (19).  
 
Despite the optimistic results from our cross-validation phase, they do not agree with those 
found by O’Neill et al. (22), which showed that HR prediction based on RPE underestimated the 
observed HR values in pregnant women. O’Neill’s results can be explained by the predictive 
approach taken to calculate HR based on RPE that these authors used. Essentially, they added a 
“0” value to the 6-20 RPE Borg Scale, representing participants’ HR. Although Borg (6) 
suggested that the 6-20 values corresponded to HR ranges from 60-200 beats·min-1, it was also 
mentioned that a given exercise session that evokes a HR of 150 beats·min-1 may be assigned an 
RPE of either 13 or 17 as a result of a multitude of physical and emotional factors. Ideally, both 
HR and RPE should be used together to monitor exercise intensity (6), which was acknowledged 
by O’Neill et al. (22). In lieu of adding a “0” value to the RPE scale to predict HR values, we 
followed the same approach (i.e., simple linear regression) as the one used in pregnant women 
by Davenport et al. (10) to determine the HR ranges. 
 
The RPE target ranges found in the current study showed an overlap between the upper limit 
for light-intensity and the lower limit for moderate-intensity RPE values in both younger (i.e., ≤ 
29 years; RPE = 12) and older pregnant women (i.e., ≥ 30 years; RPE = 11). These differing results 
were observed because the RPE values obtained from the prediction equation were rounded as 
a necessity. As 6-20 RPE values are not commonly reported using decimals, we deemed that 
rounding was acceptable. 
 
Overall, this study has important strengths. The statistical procedures used to determine 
appropriate RPE targets were based on similar methods employed by Davenport et al. (8). 
Additionally, the cross-validation (Study Phase 3) was based on a moderate-intensity PA session 
with both women who were exercising within the HR guideline targets (i.e., Step 1) and those 
exercising outside the HR guideline targets according to their resting HR (i.e., Step 2). The study 
also has limitations. Only women in their 2nd trimester were studied, similar to the HR target 
ranges described in the Canadian PA Guideline (19), and we cannot assure this will be applicable 
in other pregnancy time points (i.e., earlier or later in pregnancy). Also, we included pregnant 
women who were classified as normal and overweight, while Davenport et al. (10) included 
women categorized as overweight or obese in their study to develop the HR target ranges. The 
reason for analyzing both women categorized as normal-weight and overweight in the present 
study is that the current Canadian PA Guideline (19) extrapolated the HR target ranges for those 
Int J Exerc Sci 13(3): 1340-1351, 2020 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
1349 
in all BMI categories. Due to the small sample size (n=9 classified as normal weight and n=4 
considered overweight), we could not perform our analysis separately between BMI categories. 
On a similar note, the impact of gestational weight gain on these RPE ranges was not assessed 
in the present study. Based on self-reported PA questionnaire assessment, we found that many 
of our participants reported being quite active (unpublished data), but none of them were 
actively engaged in exercise training (i.e., systematic and prescribed training). As this study 
included only 13 women, we opted not to include this self-reported data in the analysis since 
subjective data have been found to overestimate PA levels in pregnancy (7). One more 
shortcoming is that the same set of pregnant women were used in the cross-validation, although 
we have changed the exercise modality (i.e., submaximal incremental test to continuous exercise 
session). Lastly, vigorous-intensity PA was not examined in our study. More studies are 
required to fully understand the benefits of exercising at higher intensities during pregnancy, 
although there is evidence showing positive maternal and fetal outcomes (4). Given these 
limitations, future studies should examine the influence of pre-pregnancy BMI categories, 
gestational weight gain, PA levels, and other exercise modes and intensities on the relationship 
between HR and RPE during exercise.  
 
We concluded that RPE ranges for light- and moderate-intensity PA for pregnant women aged 
≤ 29 years old should be 8-12 on the 6-20 Borg RPE scale, whereas Borg 12-15 reflects moderate-
intensity. Women aged ≥ 30 years old should perform light-intensity PA within the range of 8-
11 and moderate-intensity in the range of 11-14 using the same scale. The cross-validation phase 
suggested no differences between predicted vs. observed RPE values and a strong percentage 
of agreement between the observed RPE and its predicted range. The availability of appropriate 
RPE ranges will ultimately guide the monitoring of exercise-intensity by exercise professionals, 
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